Remitly Global Set To Join S&P SmallCap 600 Will Replace Apellis Pharmaceuticals

Benzinga Newsdesk www.benzinga.com Neutral 92.1%

Neg 0% Neu 92.1% Pos 0%

https://www.spglobal.com/spdji/en/documents/indexnews/announcements/20260507-1483310/1483310_tph-apls-6.pdf

Comments

No comments yet. Be the first!